Analysis of subgroups of patients with active musculoskeletal and hematological manifestations, active lupus nephritis, positive anti-dsDNA, anti-Sm, and anti-SSA autoantibodies at enrollment did not reveal any factors associated with achieving remission and LLDAS. This evidence concerns the gene CALR and lupus nephritis.